These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 9805587)

  • 1. Attention deficit hyperactivity disorder and anxiety: is there an association with neurodevelopmental deficits?
    Vance AL; Luk ES
    Aust N Z J Psychiatry; 1998 Oct; 32(5):650-7. PubMed ID: 9805587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention deficit hyperactivity disorder: anxiety phenomena in children treated with psychostimulant medication for 6 months or more.
    Vance AL; Luk ES; Costin J; Tonge BJ; Pantelis C
    Aust N Z J Psychiatry; 1999 Jun; 33(3):399-406. PubMed ID: 10442797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder.
    Pliszka SR
    Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):525-40, vii. PubMed ID: 10944655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Coughlin CG; Cohen SC; Mulqueen JM; Ferracioli-Oda E; Stuckelman ZD; Bloch MH
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):611-7. PubMed ID: 26402485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
    Pliszka SR
    J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Attention-deficit/hyperactivity disorder (ADHS) in adulthood].
    Kordon A; Kahl KG
    Psychother Psychosom Med Psychol; 2004; 54(3-4):124-36. PubMed ID: 15037976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit/hyperactivity disorder across the lifespan.
    Wilens TE; Biederman J; Spencer TJ
    Annu Rev Med; 2002; 53():113-31. PubMed ID: 11818466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is attention-deficit hyperactivity disorder (ADHD)?
    Furman L
    J Child Neurol; 2005 Dec; 20(12):994-1002. PubMed ID: 16417850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle.
    Spencer T; Biederman J; Wilens T; Harding M; O'Donnell D; Griffin S
    J Am Acad Child Adolesc Psychiatry; 1996 Apr; 35(4):409-32. PubMed ID: 8919704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stimulants revisited.
    Wilens TE; Spencer TJ
    Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):573-603, viii. PubMed ID: 10944658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adult attention deficit/hyperactivity disorder, associated symptoms and comorbid psychiatric disorders: diagnosis and pharmacological treatment].
    Paslakis G; Schredl M; Alm B; Sobanski E
    Fortschr Neurol Psychiatr; 2013 Aug; 81(8):444-51. PubMed ID: 23864520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention deficit hyperactivity disorder: current progress and controversies.
    Vance AL; Luk ES
    Aust N Z J Psychiatry; 2000 Oct; 34(5):719-30. PubMed ID: 11037357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention deficit hyperactivity disorder, combined type: better executive function performance with longer-term psychostimulant medication.
    Vance AL; Maruff P; Barnett R
    Aust N Z J Psychiatry; 2003 Oct; 37(5):570-6. PubMed ID: 14511085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sluggish cognitive tempo is associated with academic functioning and internalizing symptoms in college students with and without attention-deficit/hyperactivity disorder.
    Becker SP; Langberg JM; Luebbe AM; Dvorsky MR; Flannery AJ
    J Clin Psychol; 2014 Apr; 70(4):388-403. PubMed ID: 24114716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of parent- and child-reported anxiety in psychostimulant medication naïve, clinically referred children with attention deficit hyperactivity disorder, combined type (ADHD-CT).
    Vance A; Costin J; Barnett R; Luk E; Maruff P; Tonge B
    Aust N Z J Psychiatry; 2002 Apr; 36(2):234-9. PubMed ID: 11982546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collicular dysfunction in attention deficit hyperactivity disorder.
    Overton PG
    Med Hypotheses; 2008; 70(6):1121-7. PubMed ID: 18215471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD).
    Perugi G; Pallucchini A; Rizzato S; Pinzone V; De Rossi P
    Expert Opin Pharmacother; 2019 Aug; 20(12):1457-1470. PubMed ID: 31112441
    [No Abstract]   [Full Text] [Related]  

  • 19. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view.
    Rowland AS; Lesesne CA; Abramowitz AJ
    Ment Retard Dev Disabil Res Rev; 2002; 8(3):162-70. PubMed ID: 12216060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory.
    Barnett R; Maruff P; Vance A; Luk ES; Costin J; Wood C; Pantelis C
    Psychol Med; 2001 Aug; 31(6):1107-15. PubMed ID: 11513378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.